Novo Nordisk Reportedly Launches Ozempic in India

MT Newswires Live
2025/12/12

Novo Nordisk (NVO) has launched its popular Ozempic drug in India, pricing the 0.25-milligram dose at $24.35 a week, news outlets reported Friday.

The Danish pharmaceutical giant has set monthly prices of the diabetes treatment at 8,800 Indian rupees ($97.24) for the 0.25-mg dose, 10,170 rupees for 0.5-mg, and 11,175 rupees for the 1-mg dose, according to reports. Each pen reportedly contains four weekly doses.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10